Schedule 4 to the Principal Order is amended as follows:

(a) by omitting item 40013 and substituting the following:

40013.	Acetylcysteine except –
	(a) when included in Schedule 2 ; or
	(b) in preparations for oral use when labelled with a recommended daily dose of 1g or less of acetylcysteine.

(b) by inserting after item 40029 the following:

40029F.

Agalsidase alpha.

(c) by omitting item 40183 and substituting the following:

40183.

Benzylpenicillin.

(d) by inserting after paragraph (b) in item 40194 the following:

40194M.

Bimatoprost.

(e) by omitting item 40493 and substituting the following:

40493.

Dihydrostreptomycin.

(f) by inserting after item 40558 the following:

40558M.

Eflornithine.

(g) by inserting after item 40584 the following:

40584M.

Ertapenem.

(h) by omitting item 40674 and substituting the following:

40674.

Flurbiprofen except when included in Schedule 2 .

(i) by omitting item 40782 and substituting the following:

40782.	Ibuprofen except –
	(a) when included in Schedule 2 ; or
	(b) in preparations for dermal use.

(j) by inserting after item 40800R the following:

40800U.

Insulin-like growth factors except when separately specified in this Schedule.

(k) by omitting item 41096 and substituting the following:

41096.

Novobiocin.

(l) by inserting after item 41111 the following:

41111M.

Omalizumab.

(m) by inserting after item 41161 the following:

41161M.

Parecoxib.

(n) by omitting item 41190 and substituting the following:

41190.

Phenethicillin.

(o) by omitting item 41199 and substituting the following:

41199.

Phenoxymethylpenicillin.

(p) by inserting after item 41241 the following:

41241M.	Polyacrylamide in preparations for injection or implantation –
	(a) for tissue augmentation; or
	(b) for cosmetic use.

(q) by omitting item 41271 and substituting the following:

41271.

Procaine penicillin.

(r) by inserting after item 41328 the following:

41328M.

Rasburicase.

(s) by inserting after item 41338 the following:

41338M.

Riluzole.

(t) by omitting item 41416 and substituting the following:

41416.

Streptomycin.

(u) by inserting after item 41471 the following:

41471M.

Tenofovir.

(v) by inserting after item 41606 the following:

41606M.

Valganciclovir.

(w) by inserting after item 41631 the following:

41631M.

Voriconazole.